Introduction
Clinical in vitro diagnostics and effective cancer or viral therapies require accurate detection of proteins or haptens.
1,2 A hapten is defined as a low-molecular-weight compound, which is not immunogenic, but is immunoreactive; namely, it can react with anti-hapten antibodies. 3 A classic case is a steroid family that contains a characteristic arrangement of four cycloalkane rings joined to each other. Many steroids are indispensable targets for diagnosis and treatment, since they play significant physiological and pathological roles in our daily lives. However, due to their limited surface area, haptens are analytes that are difficult to detect and track. 4 Furthermore, steroids are problematic to be discriminated, since they are a large family of molecules of similar hydrophobicity that chemically, and structurally resemble each other, with only slight differences in the number and position of substitutions at the skeleton derived of gonane (Fig. 1A) . Especially, 17β-estradiol (E2) is considered to be an important detection target, not only in clinical diagnostics of female-related disorders and diseases, but also in environmental monitoring, since it is reportedly the substance with the strongest estrogenicity.
The methods for detecting steroids include LC-MS, receptor binding assays, and immunoassays. Among them, competitive immunoassays, such as fluorescence immunoassays and enzyme-linked immunosorbent assays (ELISAs), are widely used, because of their sensitivity and specificity, owing to the use of antibodies. However, due to their competitive detection mode, the methods generally have limited sensitivity as well as a narrow working range governed by the equilibrium dissociation constant. As a means to detour these problems, the open-sandwich immunoassay (OS-IA) was established for the noncompetitive detection of small molecules. [5] [6] [7] It utilizes the nature of an antibody variable region comprised of two domains, VH and VL, where re-association of the two separated domains is enhanced in the presence of an antigen. By measuring the interaction between VH and VL fragments of cloned recombinant antibodies by ELISA (OS-ELISA), the assay can noncompetitively detect many kinds of haptens with a wider working range, and can attain a lower detection limit than corresponding competitive assays. [8] [9] [10] Also, the principle behind the assay is applicable to the selection of antibodies with superior affinity, which we call open-sandwich (OS) selection (Fig. 1B) . 11 A potential merit of OS-selection for selecting a small molecule binder is that it does not rely on any antigen-conjugates, meaning no risk of selecting clones that bind only to the hapten-carrier conjugate, which is a commonly observed problem in selecting hapten-binding antibodies. Taking this merit, we introduced OS selection for affinity maturation of phage-displayed VH fragments of an anti-E2 antibody. Surprisingly, while the obtained clones showed moderate improvement in sensitivity in OS-ELISA, a clone showed significantly improved selectivity for E2 over testosterone (TS), which had shown high cross-reactivity (CR) in the original antibody.
Experimental

Materials
The phagemid pIT2 12 was kindly provided by Dr. Ian Tomlinson. Escherichia coli XL-10 Gold (Stratagene, La Jolla, CA) was used for DNA manipulation, TG-1 (GE Healthcare, Tokyo, Japan) for phage display, and BL21 (DE3, pLysS) (Novagen, San Diego, CA) for the expression of MBP-VL and MBP-VH fusion proteins. All restriction and modification enzymes were from New England Biolabs (Tokyo, Japan), Toyobo (Osaka, Japan), Takara-Bio (Shiga, Japan), or Roche Diagnostics (Tokyo, Japan).
Oligonucleotides were synthesized by Fasmac Co. Ltd. (Kanagawa, Japan), which are listed in Table S1 (Supporting  Information) . Other chemicals, reagents, and antibodies, unless otherwise indicated, were obtained from Sigma (St. Louis, MO) or Wako Pure Chemicals (Osaka, Japan). The composition of media and buffers used are listed in Table S2 (Supporting  Information) .
Cloning of anti-estradiol antibody V-region genes
The V-region genes (VH and VL) of an anti-estradiol antibody were cloned from a hybridoma ES1 using the pDong phage display system. 13 Briefly, total RNA was extracted from ES1 cells, and used for RT-PCR using V-region specific primers. The amplified VH fragments were digested with restriction endonucleases, SfiI and XhoI, and inserted into phagemid pDong1 digested with the same enzymes. After insertion, the vector was amplified, digested with SalI and NotI, and VL fragments digested with the same enzymes inserted. The library of phagemids was used to produce phage particles by infecting the KM13 helper phage, 14 and the phage was used for a round of biopanning on an Immunotube (Nunc, Nalgenunc) precoated with 1 μg/mL E2-BSA (Sigma) in PBS at 4 C for 16 h. After extensive washing, the bound phage particles were eluted with 1 mL 1 mg/mL TPCK-treated trypsin (Sigma) in PBS at 25 C for 5 min under rotation. The eluted phages were used to infect fresh TG-1 cells, in order to make monoclonal phages. A positive clone that showed strong E2-BSA binding in the phage ELISA (ES1-11) was picked and used in a subsequent study. The nucleotide sequences for the genes were determined by Fasmac Co. Ltd.
Preparation of MBP-VL, VH-SEAP, and MBP-VH-Flag-His fusion proteins
The fusion protein of E. coli maltose binding protein (MBP) and VL was expressed using pET-MBP-VL(ES1-11) plasmid, as described. 15 To express the VH-secreted human placental alkaline phosphatase (VH-SEAP) fusion protein in mammalian cells, the VH(ES1-11) gene was amplified with primers VHES1MfeBack and VHAflFor2, and cloned into pVHiSEAP-His 16 between the MfeI and AflII sites. The vector was used to transfect simian COS-1 cells using Lipofectamine 2000 (Invitrogen), as described, and the culture supernatant was recovered 60 h after transfection. To prepare MBP-VH fusion protein with Flag tag, the VH gene was amplified with primers M13RV and VHFlagNotFor, digested with SfiI and NotI, and cloned into pET-MBP-VH between the same sites. The expression and purification of the protein were performed as described for MBP-VL.
Construction of mutant VH library
The VH gene was mutated by error-prone PCR, as described. 17 The reaction mix (100 μL) contained 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 0.1% (w/v) Triton X-100, 0.5 mM MnCl2, 2.5 mM MgCl2, 1 mM dCTP and dTTP, 0.2 mM dGTP and dATP, 8 U Taq DNA polymerase, and 500 nM each of primers M13RV and JH2Notfor (pH 9.0). The DNA was amplified by PCR for 30 cycles (94 C/1 min, 62 C/1 min, 72 C/4 min). The amplified VH fragment was gel purified, digested with restriction enzymes SfiI and NotI, and cloned back into pIT2 digested with the same enzymes using T4 DNA ligase at 16 C for 16 h at a vector/insert ration of 1:5. The product was ethanol precipitated, dissolved in sterile water and electroporated to freshly prepared E. coli TG-1 competent cells in three aliquots of 100 μL. After the pulse, a part of the cells was plated onto YTAG agar plate and incubated overnight at 37 C. The number of colonies on the plates was counted to estimate the library size.
The remaining cells were cultured in 1 L of 2YTAG medium at 37 C with shaking at 200 rpm. When OD600 reached 0.5, the KM13 helper phage was added at a moi of 20, and incubated for 30 min at 37 C without shaking. After being centrifuged at 2300g for 10 min, the pellet was resuspended in 1 L of 2YTAK medium and incubated with vigorous shaking at 30 C overnight. The culture supernatant was prepared by centrifugation at 2300g for 25 min, and phages were precipitated with 0.2 vol of PEG/NaCl on ice for 1 h. After centrifugation at 6000g for 30 min, the pellet was resuspended in TE and re-centrifuged at 16000g for 10 min at 4 C. The supernatant containing the phage particles was stored at 4 C.
Open-sandwich (OS) biopanning
A 96-well microplate was immobilized with MBP-VL at a concentration of 2 μg/mL; then, a 1 × 10 10 cfu phage solution and E2 were added to the wells, which were washed with PBST after incubation at room temperature for 2 h. Phages bound to the solid surface were eluted with 100 μL of 1 mg/mL TPCK-treated trypsin in PBS for 10 min. The eluted phage solution was used to infect TG-1 cells in log phase, which were then plated on 2YTAG agar plates, and used for phage preparation. Three rounds of biopanning were performed. The antigen concentration decreased from one round to another; specifically, it was 20 ng/mL in round 1, 4 ng/mL in round 2 and 0.5 ng/mL in round 3, respectively.
Open-sandwich ELISA
For chemiluminescent ELISA, a 96-well Costar white microplate (Corning, NY, USA) was incubated with 100 μL of 2 μg/mL MBP-VL in PBS overnight at 4 C, and then each well was blocked with 20% Immunoblock (DS Pharma, Osaka, Japan) in PBS (IPBS) for 2 h at room temperature. The microplate was then washed three times with PBS containing 0.1% Tween-20 (Sigma) (PBST), and 50 μL of culture supernatant containing VH-SEAP as well as 50 μL of antigen in PBS containing 2% EtOH were added before incubation for 1 h at 25 C. After extensive washing with PBST, the wells were incubated with 100 μL CDP star (New England Biolabs) for 30 min, and chemiluminescence was measured using a microplate luminometer AB-2350 (ATTO, Tokyo, Japan).
Colorimetric ELISA was performed on a 96-well PVC microplate (Falcon 353912, BD Bioscience) with 100 μL of MBP-VL immobilized in PBS at 4 C overnight. For phage ELISA, after removing the 2 μg/mL MBP-VL solution, the plate was blocked with 2% skim milk in PBS (MPBS) for 2 h at 25 C. After washing three times with PBST, 100 μL of 2 × 10 10 cfu/mL VH phage mixed with serially diluted antigen in PBST was added to the wells, and incubated at 25 C for 1 h. After washing three times with PBST, each well was reacted with 100 μL of 5000-fold diluted HRP-conjugated mouse anti-M13 monoclonal antibody (GE Healthcare) in 2% MPBS for 1 h at 25 C.
For ELISA with MBP-VH-His-Flag, after the well was coated with 14 μg/mL MBP-VL and blocked with IPBS, MBP-VHHis-Flag protein (14 μg/mL) and antigen diluted in 100 μL IPBS were added and incubated for 1 h at 25 C. After being washed three times with PBST, each well was incubated at 25 C with 100 μL of 5000-fold diluted HRP/anti-Flag M2 (Sigma) in IPBS for 1 h.
After washing three times with PBST, 100 μL of TMBZ solution was added, and incubated for 5 -30 min. The reaction was stopped with 50 μL of 1 M sulfuric acid, and the absorbance was read using a microplate reader (Model 680, Bio-Rad, Tokyo, Japan) at 450 nm with a reference at 655 nm. The EC50 and IC50 with corresponding standard error values were obtained using Kaleida Graph (Synergy Software, Reading, PA) by curve fitting to a four-parameter logistic equation, where c represents EC50 or IC50:
Competitive ELISA
To make single-chain Fv (scFv) genes, where the VH and VL genes are linked by (G4S)3 linker sequence, the VH gene from pIT2 with either the wild-type or a mutant sequence was amplified by PCR with primers M13RV and G4SJH2For, while the VL gene in pET-MBP-VL was amplified with G4S2Vk1 and T7term. The two PCR products were purified and assembled by SOE (Splicing by overlapping extension) PCR with M13RV and T7term as primers. The product was gel-purified and digested with SfiI and NotI, and ligated to either pIT2 or pET-MBP-VL digested with the same enzymes before transformation. Colonies containing scFv fragment plasmids were screened by PCR, and confirmed for their sequences. The scFv-displaying phages and MBP-scFv proteins were prepared as described above.
For competitive phage ELISA, a microplate was incubated with 100 μL per well of 2 μg/mL E2-BSA in PBS overnight at 4 C, and blocked with MPBS for 2 h at 25 C. After washing three times with PBST, the well was added with a final 100 μL of 2 × 10 10 cfu/mL scFv-phage in MPBS, mixed with serially diluted antigen in 2% EtOH/PBS, and incubated at 25 C for 1 h. The bound phages were detected as described above.
For competitive protein ELISA, the microplate well immobilized with E2-BSA was blocked with IPBS for 2 h at 25 C, and washed three times with PBST. After 100 μL of IPBS containing 2 μg/mL MBP-scFv and antigen diluted to various concentrations were added, the microplate was incubated for 60 min at 25 C, washed three times with PBST, and then incubated at 25 C with 100 μL of 5000-fold diluted HRP/anti-His monoclonal conjugate in IPBS for 1 h before colorimetric detection, as described above.
Construction of E85R mutant VH
Two PCRs were performed with primer sets, M13RV/H85Rfor and H85back/pHENseq, with pIT2-VH(ES1-11) as a template. The purified PCR products were assembled by SOE PCR with primers M13RV and pHENseq. The product was digested with SfiI and NotI, and recloned to pIT2 digested with the same enzymes. The phage displaying the mutant VH fragment was produced as described above.
Results and Discussion
Cloning of anti-E2 V-region genes for OS-ELISA
To make an OS-IA system for E2, we cloned the genes from a hybridoma cell line expressing anti-E2 antibody by using the pDong1 phage display system. After a round of biopanning with E2-BSA, a specific clone (ES1-11) whose fragment for antigen binding (Fab, heterodimer of VH+CH1 and L chain) displayed on M13 phage reacted strongly to immobilized E2-BSA was obtained. To perform OS-ELISA, we recloned the VH and VL genes encoded in the phagemid to the 5′-terminus of the secreted human placental alkaline phosphatase (SEAP) gene of the mammalian expression vector pSEAP-His, and to the 3′-terminal of maltose binding protein gene in the bacterial expression vector pET-MBP, respectively, to obtain VH-PLAP and MBP-VL fusion proteins. The result of a chemiluminescent OS-ELISA with immobilized MBP-VL and the culture supernatant containing VH-SEAP as a reporter showed a good dose-response for E2 with a high signal-to-background ratio (Fig. 1C) . However, the result also showed moderate sensitivity and high CR [(EC50 for E2/EC50 for analog)× 100(%)] to the analogous steroid testosterone (TS) (~17%), which was also observed in the original antibody (data not shown). Meanwhile, since the background signal without an antigen was low, we thought that we could possibly improve the sensitivity and/or selectivity of the assay by utilizing OS selection.
Construction of randomized VH library
The scheme of OS selection is depicted in Fig. 1B . Since the VH fragment of an antibody generally plays a larger role than the VL in specific antigen binding, partly due to its longer third complementarity determining region CDR3, 18 the VH fragment of the anti-E2 antibody ES1-11 was targeted for random mutagenesis with the aim of improving its affinity to free E2 molecules. To construct the VH gene library, the VH gene was randomly mutated by error-prone PCR, and the amplified fragments were ligated to a phagemid vector pIT2. As a result, 8 × 10 7 independent transformants were obtained. From the nucleotide sequencing of eight clones of the library, the average number of point mutations within the VH gene was 5.5 with a standard deviation of 1.8.
OS selection of specific E2-binding phage
To select and enrich E2-specific mutant clones, the randomly mutated VH library was displayed on phage particles, and isolated by three rounds of OS biopanning on MBP-VL. During the selection, increasing stringency was adopted by reducing the amount of E2 from one round to another. In each round, the phages bound to the solid-phase were eluted by trypsin, which was proven to be effective to reduce the elution of nonspecifically bound phages. 12 For each round, an input of about 10 10 cfu phages resulted in the recovery of ~10 5 cfu phages. After the third round, the colonies made from the recovered phages were used to prepare monoclonal VH phages, and screened by OS phage ELISA (Fig. 1D) . According to the result, a clone M6 exhibited stronger signal, especially at lower E2 concentration, while another clone, M2, showed a generally higher signal than M6 or the wild-type (M7, that had Q5amber mutation, in which the codon for Gln5 was mutated to amber stop codon, which is read as the same Gln in TG-1 amber suppressor strain). Because M2 had multiple mutations including amber codon at Gln6, and also showed a higher background signal, we decided to pickup M6 for further study.
Phage OS ELISA of clone M6
To investigate the performance of clone M6 in OS-ELISA, phages displaying the mutant VH were prepared and evaluated for their reactivity to related steroids including TS ( Fig. 2A) . According to the obtained dose-response curves, the M6 VH-phage showed a good E2-dependent signal increase with an EC50 of 73 ± 8 nM, which was 4.9-fold lower value than attained in the previous OS-ELISA with VH-SEAP (360 ± 18 nM) (Fig. 1C) . To our surprise, the M6 VH-phage showed a significantly lower response to TS, with a calculated EC50 of 30 mM. In other words, the mutation found in clone M6 (E85K) resulted in not only increased sensitivity for E2, but also in the decreased reactivity to TS in phage OS-ELISA. Also, low reactivity to another analog cortisol was observed, as in the case of the wild-type VH.
Competitive phage ELISA
To compare the affinity and specificity of M6 and the wild-type in a more traditional assay format, single chain Fv fragments (scFv, VH-VL) were constructed and displayed on phages as before. Using the same titer of scFv-phages, thus made, an indirect competitive phage ELISA was performed on the microplate wells with immobilized E2-BSA in the presence of varied amounts of E2 or TS (Fig. 2B) . In general, a higher signal was observed for M6 than the wild-type VH-phages. For the phage displaying wild-type scFv, the IC50 for E2 and TS were 34.5 ± 1.2 and 109 ± 33 nM, respectively, and the resulting CR was as high as 31.7%. On the contrary, the phage displaying clone M6 scFv showed an IC50 for E2 and TS of 28 ± 5 and 440 ± 150 nM, respectively, resulting in a 5-fold improved CR (6.4%). Although these values are not so impressive when compared with the EC50 difference in OS phage ELISA, significant improvements in both sensitivity to E2 and in specificity against TS were observed for the mutant.
ELISA using MBP fusion proteins
To further confirm the improved affinity and specificity of M6, OS and competitive ELISA with purified proteins were performed. To this end, E. coli maltose binding protein (MBP) was used as a fusion partner of VH and scFv fragments to stabilize and increase their expression yields. For the specific detection of the MBP-VH in the presence of immobilized MBP-VL, Flag-tagged MBP-VH proteins were constructed, and detection was performed with an anti-Flag-HRP conjugate. In OS-ELISA with the same amount of MBP-VH proteins, dose-response curves similar to those obtained by previous OS-ELISA were obtained (Fig. 2C) . For the wild-type MBP-VH, the calculated EC50 for E2 and TS were 360 ± 70 and 540 ± 350 nM, respectively, resulting in a very high CR to TS (66.7%). On the contrary, that of the mutant M6 showed the calculated EC50 for E2 and TS of 210 ± 10 and 6.9 ± 16 μM, respectively, resulting in a 22-fold improved CR of 3.0%. It is worth noting that M6 showed a smaller error in EC50 for E2, reflecting its smaller signal fluctuation than the wild-type.
To compare the affinity and specificity of M6 and the wild-type as a paired variable region, MBP-scFv proteins were used for indirect competitive ELISA with immobilized E2-BSA, as before. As shown in Fig. 2D , MBP-scFv of clone M6 showed a somewhat stronger signal than the wild-type, and stronger inhibition by E2 as well as weaker inhibition by TS, as in the case of phage ELISA. For the wild-type MBP-scFv, the IC50 for E2 and TS were 36.7 ± 3.2 and 117 ± 7 nM, respectively, resulting in a CR of 31.4%. On the contrary, that of M6 showed IC50 for E2 and TS of 27.1 ± 0.8 and 183 ± 19 nM, respectively, resulting in a 2.1-fold improved CR of 14.8%. Although the extent of improvement was not as large as observed in phage ELISA, significant differences both in IC50 and in CR for TS were observed in protein ELISA, further confirming the improved performance of clone M6. Also, it is worth noting that when clone M6 was used, compared with competitive ELISA, a wider detectable working range of more than 3 decades was attained with OS-ELISA, while keeping similar sensitivity and higher selectivity.
Investigation of possible mechanism for specificity improvement by E85R mutation
As described, the mutant M6 had a single point mutation (CAG to AAG) at the codon for residue 85 (in Kabat numbering scheme), 19 which resulted in the change from Glu (E) to Lys (K) (Fig. S1B, Supporting Information) . In order to examine the functional role of this mutation, the same position was mutated to another positively charged amino acid Arg (R). After the mutant VH(E85R) gene was constructed, the VH-displaying phage was prepared as before, and an OS phage ELISA was performed. As shown in Fig. S1A (Supporting Information), while the mutant (E85R) showed a lower E2 dose-response than the wild-type, it also had a similar behavior to clone M6 in terms of decreased cross-reactivity to TS. The result might suggest that the change of the negatively charged Glu to a positively charged residue at this position was a key determinant in its increased discrimination of TS.
According to a molecular model constructed by the homology modeling of the wild-type ES1-11 Fv using the WAM antibody modeling server, 20 the residue 85 sits near to one of the bottom loops distant from the antigen-binding site (Fig. S1C , Supporting Information) (The Cα-Cα distance of E85 and W103 at the bottom of the antigen binding pocket is 23.5 Å). Considering the importance of a positive charge introduced by the mutation, at least a part of the improvement in specificity would be explained by a long-range Coulomb charge effect. Possibly, the partial negative charge of E2 at its 3-OH that is absent in TS is stabilized by the introduced positively charged side chain, thus resulting in increased affinity and recognition specificity for E2 molecules.
Conclusions
To our knowledge, this is the first time when OS-selection was applied for an anti-hapten antibody. In this sense, this is the first OS-selection whose merit of not needing antigen conjugate for the selection has been fully exploited. As illustrated in Fig. 1B , the OS selection approach can avoid the preferential selection of antibodies recognizing the conjugated form or the conjugated carrier rather than the hapten alone, which represents only one of many potential epitopes. 21 Apart from this, further shortcomings of conjugation also include a possible distortion of the hapten structure, and an adverse effect of the coupling position on the antibody affinity and specificity to haptens. This is especially the case for steroids like E2, which are small and rigid molecules with only a few functional groups capable of specific interactions with antibodies. [22] [23] [24] The obtained mutant VH with an increased selectivity and specificity contains a mutation of a surface residue distant from the antigen-binding site. Apparently, this mutation (E85K) leads to a charge change from -1 to +1, which could be responsible for the stronger binding to negatively charged E2 and poorer binding to neutral TS. 25, 26 However, an analogous mutant, E85R, exhibited limited improvements in binding affinity to E2, suggesting the limit of this hypothesis.
An alternative possible explanation would be an improved stability of the M6 VH fragment. It is known that mutations of surface residues can result in improved protein stability, including that of VH domains, 27 and rational optimization of charge-charge interaction on the protein surface is a way of enhancing protein stability. 28 This explanation is attractive, since the specificity improvement over TS is more clearly observed in OS-ELISA, rather than in competitive ELISA using scFv, which are generally more stable than the isolated VH domain. Also, the differences in signals between the wild-type and M6 in ELISAs imply differences in their protein stability both in VH alone, and in the scFv format.
Moreover, in general, if we randomize the VH fragments with limited stability for OS selection, more stable VH fragments that show tighter binding to VL in the presence of an antigen are likely to be enriched. It is possible that such stabilization can result in higher selectivity of the obtained clones. If we use conventional selection with scFv or Fab with higher stability than VH alone for randomization, the selection pressure for a more stable V region will not be as high as in OS selection. Hence, there is a possibility that OS selection is better suited to improve the selectivity of antibodies. The experiments to measure the stability of isolated VH and scFv fragments are now under way.
Finally, a possible reason for reduced improvements in sensitivity and selectivity observed in protein ELISAs might be due to fusion with MBP, since MBP has an intramolecular chaperone activity and stabilizes its partner, in this case VH and scFv, even for the unstable wild-type. 29 Theoretically, nonspecific binding of the fused MBP moiety to E2-BSA and TS might also show their increased competition. However, such multiple competitive reactions would not give good competition curves, as in Fig. 2D .
In conclusion, unlike conventional methods, antigen conjugation is not necessary in OS selection, and the selected VH mutants can be directly applied for OS-IAs. 10, 30, 31 We hope that OS selection and the OS-IA system could open possibilities for the further development of good hapten-specific antibodies and innovation in small molecule detection.
